KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Combination Product: Ravulizumab OBDS (Ultomiris (TN))	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
2	Ravulizumab (Ultomiris (TN))	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	7件: 2, 11, 13, 50, 62, 66, 109 💬
3	Ultomiris	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	6件: 2, 11, 13, 50, 62, 66 💬
4	ULTOMIRIS - 300 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) 3 ML (100 MG / ML) - 1 FLACONCINO	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
5	Ultomiris 1,100 mg/11 mL	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 11 💬
6	Ultomiris 300 mg/30 ml	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 66 💬
7	Ultomiris 300mg/30ml	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
8	ULTOMIRIS ™ (ravulizumab-cwvz)	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
9	ULTOMIRIS®	1件: Ravulizumab (Ultomiris)	1件: Ravulizumab (Ultomiris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 13 💬